Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10460142 | 0.88 | TSHR (0.50) | TSHRALDH1A1TP53 | |
| SCHEMBL8841262 | 0.87 | TSHR (0.36) | TSHRALDH1A1TP53FOLH1 | |
| SCHEMBL98864 | 0.85 | TSHR (0.46) | TSHRALDH1A1TP53 | |
| SCHEMBL11531366 | 0.84 | ALDH1A1 (0.54) | TSHRALDH1A1TP53 | |
| Hydrochloric Acid SCHEMBL7722330 | 0.83 | TSHR (0.44) | TSHRALDH1A1TP53 | |
| SCHEMBL11528374 | 0.81 | ALDH1A1 (0.57) | TSHRALDH1A1TP53 | |
| SCHEMBL6845389 | 0.79 | TSHR (0.36) | TSHRALDH1A1TP53 | |
| SCHEMBL9888612 | 0.78 | TSHR (0.34) | TSHRALDH1A1TP53 | |
| SCHEMBL3271707 | 0.77 | TSHR (0.41) | TSHRALDH1A1TP53FOLH1 | |
| SCHEMBL29269904 | 0.76 | ALDH1A1 (0.52) | TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890351-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-13 | — | — | US | disclosed |
| EP-2741731-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-17 | — | — | EP | disclosed |
| EP-2741731-A1 | ENCAPSULATES | The Procter and Gamble Company (US) | 2014-06-18 | — | — | EP | disclosed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | disclosed |
| WO-2013022949-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2013-02-14 | — | — | WO | disclosed |
| US-6075131-A | UTILITY AS DYES FOR INK-JET PRINTING; MONOAZO DYE CONTAINING INDANYL GROUP AND ATLEAST ONE SULFONIC ACID, HYDROXY AND AMIDE OR SULFONAMIDE GROUP ATTACHED TO NAPHTHALENE RING | ZENECA LIMITED (GB) | 2000-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | TSHR 4882/4885ALDH1A1 696/4885TP53 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.